Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Long-Term Debt / Capital

Bristol-Myers Squibb Company Long-Term Debt / Capital Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Bristol-Myers Squibb Company Long-Term Debt / Capital for the quarter ending September 09, 2020 was $44m a -1.31% decrease of -1m year over year
  • Bristol-Myers Squibb Company Long-Term Debt / Capital for the last 12 months ending September 09, 2020 was $44m a -1.31% decrease of -1m year over year
  • Bristol-Myers Squibb Company Annual Long-Term Debt / Capital for 2019 was $44m a 40.67% increase of 18m from 2018
  • Bristol-Myers Squibb Company Annual Long-Term Debt / Capital for 2018 was $26m a -33.67% decrease of -9m from 2017
  • Bristol-Myers Squibb Company Annual Long-Term Debt / Capital for 2017 was $35m a 29.59% increase of 10m from 2016
Other Ratios Metrics:
  • Bristol-Myers Squibb Company Total Debt / Capital for the quarter ending December 12, 2018 was $35m a -7.68% decrease of -3m year over year
  • Bristol-Myers Squibb Company Other Liabilities for the quarter ending September 09, 2018 was $4,603m a -12.23% decrease of -563m year over year
  • Bristol-Myers Squibb Company Total Debt / Equity for the quarter ending December 12, 2018 was $53m a -12.27% decrease of -7m year over year
View Chart On Koyfin

Quarterly BMY Long-Term Debt / Capital Data

09/2020$44m
06/2020$44m
03/2020$45m
12/2019$44m
09/2019$57m
06/2019$59m
03/2019$28m
12/2018$26m
09/2018$27m
06/2018$29m

Annual BMY Long-Term Debt / Capital Data

2019$44m
2018$26m
2017$35m
2016$25m
2015$31m
2014$32m
2013$34m
2012$31m
2011$25m
2010$25m